Skip to main content
Decline in Physician Trust During the COVID-19 Pandemic

AMA reports that following the COVID-19 pandemic US adults trus

Dr. John Cush RheumNow

2 years ago
Decline in Physician Trust During the COVID-19 Pandemic AMA reports that following the COVID-19 pandemic US adults trust in physicians and hospitals decreased, and was associated with lower odds of COVID vaccination. https://t.co/3XcMYcnzD3 https://t.co/yiIvOp1o5a
Frequency and Features of CPPD

An international cohort study of patients with CPPD disease identifies both acute and ch

Dr. John Cush RheumNow

2 years ago
Frequency and Features of CPPD An international cohort study of patients with CPPD disease identifies both acute and chronic inflammatory phenotypes, each with distinctive clinical and imaging diagnostic features. https://t.co/3ox3YjVh5w https://t.co/1pB9f42a9M
Ischemic Forearm Exercise Testing is used to Dx McArdles disease & the absence of elevated blood lactate levels duri

Dr. John Cush RheumNow

2 years ago
Ischemic Forearm Exercise Testing is used to Dx McArdles disease & the absence of elevated blood lactate levels during exercise in pts w/ myophosphorylase deficiency (McArdle disease) https://t.co/pNxl6qnnIR https://t.co/kOyk45Necd
NEJM Case: A 29-year-old woman with SLE presented to the dermatology clinic with 2-weeks of itchy, painful rash on her

Dr. John Cush RheumNow

2 years ago
NEJM Case: A 29-year-old woman with SLE presented to the dermatology clinic with 2-weeks of itchy, painful rash on her nose and hands that came on with cold weather. What do you think? https://t.co/jm0Zzu1gfj https://t.co/sAgZipPmaC
Pain Reduction with Methotrexate in Knee Osteoarthritis

The Annals of Internal Medicine reports that oral, low dose, w

Dr. John Cush RheumNow

2 years ago
Pain Reduction with Methotrexate in Knee Osteoarthritis The Annals of Internal Medicine reports that oral, low dose, weekly methotrexate significantly reduced knee osteoarthritis (KOA) pain, stiffness, and function in a randomized controlled trial. https://t.co/ayMD1V67fH https://t.co/Es3oPYM8Y3
Medical literature review of suggests low vitamin D status is common in Rheumatic pts. & low vit D levels linked to

Dr. John Cush RheumNow

2 years ago
Medical literature review of suggests low vitamin D status is common in Rheumatic pts. & low vit D levels linked to loss of muscle strength, MSK pain, sarcopenia & falls (esp in IIM, PMR, SLE, RA, SSc) (BUT DOES REPLACING VITAMIN D FIX THESE PROBLEMS???) https://t.co/30IiKj7l4d https://t.co/ydU6FQMTi5
PEXIVAS: Diffuse Alveolar Hemorrhage in ANCA-Associated Vasculitis Patients

The PEXIVAS study found potential benefits

Dr. John Cush RheumNow

2 years ago
PEXIVAS: Diffuse Alveolar Hemorrhage in ANCA-Associated Vasculitis Patients The PEXIVAS study found potential benefits of plasma exchange and glucocorticoids for AAV patients with DAH, but the results did not reach statistical significance. https://t.co/m7BxMfj04W https://t.co/A9SKAWd1s5
Calcinosis cutis affects 40% of SSc pts w/ significant morbidity. Assoc w/ Long Dz duration, vascular dysfunction, &amp

Dr. John Cush RheumNow

2 years ago
Calcinosis cutis affects 40% of SSc pts w/ significant morbidity. Assoc w/ Long Dz duration, vascular dysfunction, & osteoporosis. Dx by radiography. Surgical treatment is most effective therapy, but no medical therapies have proven efficacy in RCTs https://t.co/ocQ5okBauq https://t.co/1DUm6FKfm8
Melatonin doesnt work! 172 pts w/ unilateral TKA for Rx in DBRPCT trial of qhs 5 mg melatonin vs. 125 mg vit C placebo f

Dr. John Cush RheumNow

2 years ago
Melatonin doesnt work! 172 pts w/ unilateral TKA for Rx in DBRPCT trial of qhs 5 mg melatonin vs. 125 mg vit C placebo for 6 weeks. No differences in PSQI or other sleep measures @6wks. Poor sleep assoc w/ worse pt function and pain. https://t.co/b1gfnyB7Qw https://t.co/nT589CItIF
Guselkumab maintenance dose is 100 mg sc q8wks. GUIDE ph 3b trial treated 297 PSO super responders (PASI <3) w/ q8wk

Dr. John Cush RheumNow

2 years ago
Guselkumab maintenance dose is 100 mg sc q8wks. GUIDE ph 3b trial treated 297 PSO super responders (PASI <3) w/ q8wk or extended q16wk GUS & demonstrated noninferiority of q16 wk dosing w/ disease control (91.9 vs 92.6%) https://t.co/31DPTmcVD2 https://t.co/qHMsyYCH4J
Review of Calcium Pyrophosphate Deposition Disease

Lancet Rheumatology has published a review of Calcium pyrophosphate

Dr. John Cush RheumNow

2 years ago
Review of Calcium Pyrophosphate Deposition Disease Lancet Rheumatology has published a review of Calcium pyrophosphate deposition (CPPD) disease - a chronic inflammatory and degenerative crystal arthropathy that increases with aging. https://t.co/svIGF3hM0Y https://t.co/17CNkOiGPB
×